SynthesisEuropean journal of clinical pharmacology2026
Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis.
Lingyan Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.